Medtronic (NYSE:MDT) today recalled two models of its MiniMed insulin pumps after researchers discovered cybersecurity risks that could allow a hacker to take control of the devices.
The recall affects 11 models in Fridley, Minn.-based Medtronic’s line of MiniMed 508, MiniMed Paradigm and MiniMed Paradigm Veo pumps, according to the FDA. Medtronic said the pumps are designed to wirelessly communicate with other devices such as glucose meters, glucose sensor transmitters and its own CareLink USB devices.
Get the full story at our sister site, Drug Delivery Business News